Back to search
FDAFDA · Food and drugs·Recall number D-0887-2018

Atorvastatin Calcium Tablets, 20 mg*, 90-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-122-90

Published June 27, 2018 · Recall initiated: June 12, 2018

Summary

FDA records drug Class III recall D-0887-2018, published June 27, 2018 and initiated June 12, 2018. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 44,894 bottles; Lot: Lot #: T600328, Exp 07/18; T700214, T700216, Exp 04/19. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if ATORVASTATIN CALCIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATORVASTATIN CALCIUM
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide in the USA and Puerto Rico
UPC
0355111123903
Lot
Lot #: T600328, Exp 07/18; T700214, T700216, Exp 04/19
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atorvastatin Calcium Tablets, 20 mg*, 90-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-122-90 recalled?

Yes. FDA published recall D-0887-2018 on June 27, 2018. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM. UPC: 0355111123903.